ArticleDiscover oncology2026
Intestinal mucosal Schwann cell hamartoma.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucosal Schwann cell hamartoma (MSCH) is a recently proposed disease condition. It is a benign neurofibroma that differs from neurofibromas present in type-1 neurofibromatosis. It is a form of polypoid lesion that develops in the mesenchyme, presenting with pure Schwann cell growth in the lamina propria and exhibiting diffuse S-100 protein staining. This study presents the case of a 51-year-old man, a patient who underwent routine endoscopy, which revealed a 0.5 cm polyp in the descending colon, followed by pathological and immunohistochemical examination, which verified the diagnosis of intestinal MSCH. During the subsequent follow-up, the patient had experienced no recurrence of this disease. This kind of benign intestinal neural lesion is uncommon and unique. This study aimed to increase awareness of this specific type of intestinal mucosal lesion, facilitating its identification in routine reports and revealing its potential clinical significance in the future. The diagnosis of MSCH is challenging and entirely depends on its pathology. This study enhances clinicians’ understanding of intestinal pathology, thereby improving their clinical expertise.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.